Gofen & Glossberg LLC Teva Pharmaceutical Industries LTD Transaction History

Gofen & Glossberg LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$14.59 - $23.84 $173,387 - $283,314	-11,884 Closed	0 $0
Q3 2018 Oct 11, 2018	SELL	$21.06 - $25.65 $117,304 - $142,870	-5,570 Reduced 31.91%	11,884 $256,000
Q2 2018 Jul 11, 2018	SELL	$16.77 - $24.71 $3,354 - $4,942	-200 Reduced 1.13%	17,454 $424,000
Q1 2018 Apr 11, 2018	SELL	$16.68 - $22.07 $2,502 - $3,310	-150 Reduced 0.84%	17,654 $302,000
Q4 2017 Jan 11, 2018	SELL	$11.23 - $19.1 $247,857 - $421,556	-22,071 Reduced 55.35%	17,804 $337,000
Q3 2017 Nov 16, 2017	SELL	$15.41 - $32.17 $428,028 - $893,553	-27,776 Reduced 41.06%	39,875 $702,000
Q2 2017 Aug 16, 2017	BUY	N/A	67,651	67,651 $2.25 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

Stay updated on Gofen & Glossberg LLC with notifications on news.